| Company Name | Abrax Japan, Inc |
| Founded | May 21, 2020 |
| Capital | JPY 258,166,141 |
| Address | 2-2-15 Minami Aoyama, Minato-ku, Tokyo, 107-0062, Japan |
| Chief Executive Officer, Representative Director | Jo Narita |
| Director | Yoshitake MAEDA |
| Director | Masahiro YAGI, PhD |
| Founder & Chief Scientific Advisor | Taku Kambayashi, MD, PhD （Professor of Pathology, University of Pennsylvania Perelman School of Medicine, USA） |
| Scientific Advisor | Brian Kim, MD （Associate Professor of Dermatology, Washington University School of Medicine, USA） |
| Scientific Advisor | Peter Shane, MD (Associate Professor, Hokkaido University, Japan) |
| Scientific Advisor | Shinji Kawabata, MD, PhD (Associate Professor at the Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Japan) |
| Business Outline | Research of TSLP and its medical applications |